Related by context. All words. (Click for frequent words.) 62 Squalamine 61 Valdoxan 61 prostone 60 Myocet 60 Cardio Vascu Grow 60 Celator 60 GeneSightRx 59 XmAb 59 tiapamil 59 RE COVER 59 PsychoGenics 59 HQK 58 Mipomersen 58 reslizumab 58 AZILECT ® 58 Pyridorin 58 TLK# 58 RhuDex 58 Oasmia 58 OHR/AVR# 57 PDE4 inhibitor 57 NEXTERONE 57 CardioFit 57 Clonicel 57 Factor VIIa 57 BEMA TM Fentanyl 57 REVEAL Registry 56 cancer immunotherapies 56 Aganocide 56 oral antiviral 56 BACcel 56 AssureRx 56 LibiGel ® 56 KineMed 56 Huntexil 56 R#/MEM 56 Aurora kinase inhibitors 56 intravitreal implant 56 therapeutic monoclonal antibody 56 Fabry Disease 56 YONDELIS R 56 molecular imaging radiopharmaceutical 56 Quinamed 56 novel oral anticoagulant 56 immunotherapeutic vaccine 56 ALTROPANE 56 INS# [001] 56 targeted radiotherapeutic 56 human microdosing 56 adipiplon 55 IIa trials 55 MYCAMINE 55 gefitinib Iressa 55 Archexin 55 interventional therapies 55 immatics 55 SJTRI 55 phase IIa clinical 55 Removab 55 Nanobody 55 Celacade TM 55 rxRNA 55 HuMax EGFr 55 Catabasis 55 GSK# [002] 55 Azedra 55 TriActiv R 55 CRLX# 55 NP2 Enkephalin 55 EP #R 55 Mpex 55 Pervasis 55 CAPHOSOL 55 Urocortin 2 55 JAK inhibitor 55 ProSavin 55 Altrazeal ® 55 Phase IIb clinical trials 55 cartilage regeneration 55 AMPAKINE CX# 55 Rasagiline 55 Ophena 55 recombinant factor VIIa 55 Aerosurf 55 balsalazide tablet 55 Nanobody ® 55 Mepact 54 Metricath Gemini 54 intranasal formulation 54 Chrysalin 54 clevidipine 54 ESBA# 54 EGEN 54 Zenvia Phase III 54 ganaxolone 54 GAMMAGARD 54 XP #L 54 REG1 54 HGS# 54 TRV# [001] 54 ospemifene 54 predictive toxicology 54 eprotirome 54 Hemopurifier 54 Cancidas 54 preclinically 54 non nucleoside 54 Wellstat 54 IL# PE#QQR 54 MabThera rituximab 54 TMS Therapy 54 YONDELIS 54 Lixivaptan 54 PHX# 54 BrachySil TM 54 pharmacogenetic testing 53 EC Cysteamine 53 cannabinor 53 JAK2 inhibitor 53 incyclinide 53 Ketotransdel 53 Perforomist ™ Inhalation Solution 53 isoform selective 53 Capesaris 53 Memryte 53 DXL# 53 Xcytrin R 53 external counterpulsation systems 53 oral prodrug 53 CINQUIL 53 Trofex 53 Phase Ib study 53 SNT MC# 53 Vilazodone 53 Referenced EEG 53 oral treprostinil 53 investigational therapies 53 Serdaxin 53 PORxin TM 53 thetreatment 53 trastuzumab DM1 T DM1 53 ularitide 53 Intarcia 53 Aplidin 53 aripiprazole Abilify 53 Surfaxin LS 53 CB1 antagonists 53 tubulin inhibitor 53 herpetic keratitis 53 liprotamase 53 Intraject 53 topically applied SEPA 52 Novolimus 52 Phase IIa trials 52 Ceflatonin R 52 Facet Solutions 52 Onalta 52 Aethlon Hemopurifier R 52 selective androgen receptor modulator 52 oxypurinol 52 Aryplase 52 clinical 52 LEUKINE 52 vivo preclinical 52 HCV polymerase inhibitor 52 hepatitis B vaccine Heplisav 52 FVIIa 52 subcutaneous immunoglobulin 52 nicotinic alpha 7 52 Viprinex 52 TNFerade TM 52 GGF2 52 intravenous acetaminophen 52 KuDOS 52 JAK2 inhibitors 52 Cethrin 52 ONCONASE R 52 Dalbavancin 52 Neovasc Reducer 52 IND submission 52 Plenaxis TM 52 KL4 surfactant 52 mechanical thrombectomy 52 EECP ® therapy 52 sodium thiosulfate STS 52 tasimelteon 52 PDE# inhibitors 52 Liprotamase 52 davunetide intranasal AL 52 BioMAP 52 ZEVALIN ® 51 lomitapide 51 EGS# 51 BNC# 51 DFCI 51 kinase profiling 51 Zenvia ™ 51 preclinical efficacy 51 MAXY VII 51 farletuzumab 51 Androxal TM 51 RhuDex ® 51 ALGRX 51 luliconazole 51 visilizumab 51 alemtuzumab MS 51 Cleviprex TM clevidipine 51 immunological diseases 51 cardiometabolic 51 adipose derived stem cell 51 Electronic Brachytherapy 51 TRO# 51 PD2i ® 51 microRNA profiling 51 recurrent herpes labialis 51 R#/MEM # 51 ChronVac C R 51 multicenter Phase II 51 entinostat 51 ColorectAlert TM 51 oral taxane 51 punctal plug delivery 51 sulodexide 51 gepirone ER 51 SUTENT ® 51 lexidronam injection 51 CRMD# 51 CBLC# 51 neratinib 51 Plicera 51 microplasmin Phase III 51 oral PTH 51 fosbretabulin 51 metabolite identification 51 subcutaneous formulation 51 REMINYL ® 51 biased ligand 51 Zybrestat 51 RELOVAIR ™ 51 cardio renal 51 obatoclax 51 UPLYSO 51 Proxinium 51 oral talactoferrin 51 Corlux 51 Zemiva TM 51 Cx# [002] 50 HIV integrase inhibitors 50 EECP ® 50 pharmacokinetic PK study 50 Dynogen 50 Panzem R 50 CINTREDEKIN BESUDOTOX 50 Phase 2b clinical trials 50 predictive biomarkers 50 tapentadol 50 SEPET TM 50 Altastaph 50 MYDICAR 50 Dataflow Manager 50 eniluracil 50 briakinumab 50 Rheos System 50 Xanodyne 50 vinca alkaloid 50 PREOS R 50 ICA # 50 Neo Kidney Augment 50 GEM OS2 50 CIPN 50 epigenetic therapies 50 CoFactor 50 ENMD # 50 personalized cellular immunotherapy 50 anti angiogenic agents 50 preclinical pharmacology 50 thorough QT 50 Hedgehog agonist 50 gastroenterological 50 OvaRex 50 efficacy tolerability 50 pain palliation 50 Icatibant 50 aerosolized KL4 surfactant 50 orally inhaled migraine 50 neuroimmunology 50 Bicifadine 50 procainamide 50 AERx iDMS 50 Simulect 50 lorvotuzumab mertansine 50 Hedgehog antagonist 50 Prostate Px + 50 CytoFab ™ 50 Instanyl 50 injectable formulations 50 Med eMonitor System 50 optimal dosing regimens 50 DermTech International 50 methylnaltrexone 50 Phase #/#a 50 Medifacts 50 ToleroMune 50 tafamidis 50 OvaRex ® MAb 50 EOquin TM 50 isavuconazole 50 Fentanyl TAIFUN R 50 Neurostep TM 50 DDP# 50 pertuzumab 50 Nasulin 50 Hyphanox 50 PREOS 50 SILENOR 50 bardoxolone 49 EndoTAG TM 49 MAGE A3 ASCI 49 phase IIb 49 enzastaurin 49 NTDDS 49 Phase Ib IIa clinical 49 Phase Ib clinical 49 pharmacotherapies 49 ORENCIA R 49 oral RSD# 49 Azedra TM 49 therapeutic armamentarium 49 FOLOTYN ® 49 Tectin TM 49 NovaBay Aganocide compounds 49 schizophrenia CIAS 49 IV acetaminophen 49 Phase IIB 49 dextofisopam 49 Cellegesic 49 Alocrest 49 multicenter clinical trials 49 noninfectious uveitis 49 radiolabeled TM# 49 Glybera R 49 BEXXAR 49 Cutanea 49 elotuzumab 49 temsirolimus Torisel ® 49 CLORETAZINE TM VNP#M 49 phase IIIb 49 radezolid 49 bioabsorbable stent 49 AERx 49 Neo Kidney Augment ™ 49 Zemplar Capsules 49 antagonist LAMA 49 GCP compliant 49 Targeted Chemotherapy 49 TELINTRA 49 Phase 1b trial 49 Manja Bouman CEO 49 Neuradiab 49 POSIDUR TM 49 Phase 2a clinical trials 49 constipation OIC 49 IMA# 49 Stedivaze 49 Panzem R NCD 49 TBC# 49 opioid induced bowel dysfunction 49 cangrelor 49 INOmax R 49 Phase III randomized controlled 49 Sudhir Agrawal D.Phil 49 Proxinium TM 49 phase IIb trial 49 pharmacodynamic properties 49 rHuPH# 49 PRT# 49 NTDDS platform 49 bardoxolone methyl 49 TKM ApoB 49 zileuton CR 48 intranasal insulin 48 registrational 48 teriflunomide 48 KRN# 48 antiangiogenic agents 48 MGd 48 CA9 SCAN 48 Durata 48 postapproval 48 Fibrin Pad 48 PSN# [002] 48 PICSO ® 48 ostarine 48 vernakalant hydrochloride 48 ADVANCE PD 48 candidate TNFerade biologic 48 RE LY 48 ADAGIO study 48 TRIST study 48 Prodarsan R 48 rALLy clinical trial 48 OvaRex MAb 48 canakinumab 48 Prednisporin 48 preclinical 48 RESOLUTE clinical 48 ReN# 48 Zingo TM 48 REMOXY ® 48 vemurafenib 48 INFUSE ® 48 MGN# 48 therapeutic 48 cardiotoxic effects 48 Phase IIIb study 48 phase IIa 48 sunitinib malate 48 Ceflatonin 48 Cogane 48 clinical pharmacology studies 48 zanolimumab 48 clinically validated 48 Sernova Cell Pouch 48 GLP toxicology 48 pharmacokinetic pharmacodynamic 48 Firazyr ® 48 Phase #b/#a 48 Exherin TM 48 teduglutide 48 Senetek patented 48 candidate CRLX# 48 GLPG# 48 inhalation toxicology 48 investigational HCV polymerase 48 EECP R 48 cystinosis patients 48 candidates Dyloject TM 48 Phase IIIb 48 TYZEKA 48 therapeutic antibody 48 pharmacogenetic 48 cGMP manufacture 48 Cloretazine R 48 clinicaltrials 48 postoperative ileus 48 Acute Decompensated Heart Failure 48 Solazed 48 punctal plug drug 48 haematological cancers 48 pharmacotherapeutic 48 AspenBio 48 OZURDEX ® 48 PANVAC VF 48 atherosclerosis regression 48 dermaPACE TM 48 CDRD 48 GRN# 48 MyVax ® 48 GED aPC 48 Elocalcitol 48 CytoFabTM 48 Veronate 48 COR Analyzer 48 preclinical pharmacokinetic 48 Alequel 48 OLYMPIA registry 48 CCX# 47 StemEx R 47 midstage trials 47 Annamycin 47 daptomycin 47 PFO migraine 47 rBChE 47 Rezular 47 fostamatinib 47 midstage clinical 47 RGB # 47 clinical trials 47 phase Ib 47 ticagrelor Brilinta 47 OPTTX 47 Periowave TM Photodisinfection System 47 almorexant 47 Phase Ib II 47 Phase #b/#a trial 47 PEARL SC 47 tezampanel NGX# 47 IMC #B 47 Aethlon Hemopurifier ® 47 AeroLEF TM 47 ataluren 47 Phase 2a trial 47 tolevamer 47 budesonide foam 47 hematologic oncology 47 Exelixis compounds 47 diagnostic prognostic 47 Proellex TM 47 pharmaco 47 Zoraxel 47 Triapine R 47 Evoltra ® 47 invasive candidiasis 47 Phase IIIb clinical 47 ASONEP 47 pharmacokinetic PK 47 BST CarGel R 47 IRX 2 47 TACI Ig 47 dexanabinol 47 preclinical toxicology 47 Aurexis 47 NEUGENE antisense 47 cycloserine 47 forodesine 47 postoperative ileus POI 47 GLP toxicology studies 47 SIX ROG OTCQX RHHBY 47 BRAF inhibitor 47 Desmoteplase 47 CaPre TM 47 Vascular Wrap TM 47 AFRS TM 47 INCB# [001] 47 HCD# [002] 47 lumiliximab 47 CB2 selective receptor agonist 47 ALN PCS 47 sevelamer carbonate 47 SinuNase TM 47 bicifadine 47 Referenced EEG ® 47 refractory angina 47 OraTest R 47 Tragara Pharmaceuticals Inc. 47 IIa clinical 47 Glenveigh 47 Ereska 46 TriGrid 46 Phase 1a clinical 46 Phase IIb III 46 Numoda 46 opioid induced constipation 46 Virulizin ® 46 prospective multicenter study 46 AcelRx 46 including eniluracil ADH 46 NeuroFlo 46 DPX Survivac 46 vidofludimus 46 renin inhibition 46 renal anemia 46 deforolimus 46 p# inhibitor 46 TQT studies 46 ViaCyte 46 bioequivalency 46 Zavesca r 46 Nivestim 46 HeFH 46 QLT# 46 torezolid phosphate 46 Actilon 46 Phase IIIB IV 46 OncoVEX GM CSF 46 randomized Phase IIb 46 kidney urologic 46 CCR9 antagonist 46 plaque excision 46 Combo Stent 46 Cloretazine ® 46 phase IIb study 46 VEGF Trap 46 galiximab 46 Cloretazine 46 QOPI 46 placebo controlled clinical 46 eszopiclone 46 interventional pulmonology 46 QTinno TM 46 eculizumab therapy 46 personalized immunotherapy 46 senicapoc 46 tezampanel 46 Neuradiab TM 46 UltiMAb ® 46 Zimycan 46 Dacogen injection 46 dacetuzumab 46 vilazodone 46 biomarker identification 46 genomic biomarker 46 crofelemer 46 multicentre phase 46 ADME 46 bioanalytical laboratories 46 omacetaxine 46 CYT# potent vascular disrupting 46 MyVax personalized immunotherapy 46 riociguat 46 huN# DM1 46 PMA submission 46 IIa clinical trials 46 molecular profiling 46 C1INH 46 favorable pharmacokinetic profile 46 Ketotransdel TM 46 multicentre randomized 46 clinical trial 46 acute decompensated heart 46 Accelovance 46 Sequenom CMM 46 Altrazeal TM Silver 46 Oral NKTR 45 NEUMUNE 45 GastroPlus TM 45 pharmacologic treatments 45 PD2i Analyzer 45 AzaSite Plus 45 Toraymyxin TM 45 GEM OS1 45 blood clot dissolver 45 LymphoStat B 45 RE SURGE 45 Phase IIa trial 45 Vion Pharmaceuticals 45 Syndax Pharmaceuticals Inc. 45 KINLYTIC 45 therapeutics 45 eTag assay 45 Allovectin 7 45 OncoVEX 45 Avastin adjuvant 45 safinamide 45 CellerateRx 45 non alcoholic steatohepatitis 45 Fx #A 45 Nanobodies ® 45 metaanalysis 45 phase IIb III 45 faropenem 45 Ophena TM 45 CR# vcMMAE 45 PLK1 SNALP 45 NATRECOR ® 45 EOquin 45 alvespimycin 45 torcetrapib atorvastatin 45 tipranavir 45 BioSante LibiGel Phase III 45 OvaRex R 45 HspE7 45 ZFP Therapeutic 45 Jean Pierre Sommadossi Ph.D. 45 methylphenidate hydrochloride 45 potency corticosteroid 45 RSD# oral 45 GI motility disorders 45 OMAPRO 45 FavId 45 pediatric rheumatology 45 Phase IIa clinical 45 RIGScan CR 45 ALN TTR# 45 BLA filing 45 psychopharmacological 45 PK PD 45 recurrent glioma 45 Zavesca R 45 Prednisporin TM 45 haematologic 44 ganetespib 44 systemic RNAi 44 viral kinetics 44 companion diagnostics 44 celgosivir 44 rFactor XIII 44 ophthalmology dermatology cardiovascular disease 44 pharmacogenomic testing 44 oncology 44 biologic 44 PK PD modeling 44 Voraxaze ™ 44 diabetic neuropathic pain 44 biomarker 44 QTinno 44 ELACYT 44 cerebral oximetry 44 ancrod 44 Sigma Tau SpA 44 ibandronate sodium 44 AQ4N 44 rt PA 44 PROSTVAC TM 44 pharmacogenetics 44 ATIR TM 44 BETAS 44 velafermin 44 Cethromycin 44 NTx ® -# 44 INTERCEPT platelets 44 lenalidomide Revlimid R 44 vivo pharmacology 44 oral methylnaltrexone 44 prospective nonrandomized 44 Lymphoseek ® 44 Carb Controller 44 perfusion CT 44 Sulonex 44 Tolerx 44 Hedgehog inhibitor 44 OXi# 44 intravenous methylnaltrexone 44 Opexa 44 ProTrials Research 44 fibrin sealant 44 translational medicine 44 catheter occlusion 44 ACRIN 44 rhC1INH 44 eTag assays 44 BioDisc 44 postmarket safety 44 leading oral taxane 44 Vascular Wrap 44 Q#IR 44 eosinophilic asthma 44 antithrombotic therapy 44 ruxolitinib 43 Phase IIb trials 43 Zolpidem Tartrate 43 ABSORB trial 43 multicenter trials 43 Phase 2a clinical 43 EDEMA3 43 pediatric bipolar disorder 43 M6G 43 interventional neuroradiology 43 IND enabling 43 sacral nerve stimulation 43 rEEG 43 novel therapeutic antibodies 43 anidulafungin 43 Prodarsan ® 43 AVN# [001] 43 treating neuropathic pain 43 analgesic efficacy 43 RE LY ® 43 pharmacology 43 MOZOBIL 43 ACUROX TM Tablets 43 Phase 1b clinical 43 mecarbil 43 Rhucin R 43 CARE HF 43 endocrinology oncology 43 therapeutic regimens 43 tremelimumab 43 phase IIb clinical 43 NSABP 43 Clinical 43 double blinded randomized 43 DAPT 43 invivodata 43 cytopathology 43 AZX# 43 budesonide MMX Phase III 43 CHAMPION PCI 43 severe hypercholesterolemia 43 biliary tract cancer 43 PREGNANT Study 43 Inc. Nasdaq NLTX 43 XmAb ® 43 Itopride 43 Phase 2b study 43 PORxin TM platforms 43 EchoCRT 43 Amigal 43 rheumatologic 43 Entereg R 43 Phase IIb IIIa 43 HORIZONS AMI 43 trastuzumab DM1 43 Nonclinical 43 alvimopan 43 opioid analgesia 42 REALITY Trial 42 INxin TM 42 Phase Ib 42 rALLy trial 42 Vicinium TM 42 molecular pathology 42 PRECISE trial 42 VTE prevention 42 dirucotide MBP# 42 MEND CABG 42 ACTILON 42 bioanalysis 42 null responder 42 Phase III trials 42 pivotal bioequivalence 42 biomarker discovery 42 Pharma Medica 42 investigational 42 vosaroxin 42 Adlea TM 42 THALOMID 42 tonabersat 42 rALLy 42 confirmatory Phase III 42 CLARITY study 42 micafungin 42 TKM PLK1 42 pharmacoeconomic 42 daclizumab 42 fidaxomicin Phase 3 42 procedural sedation 42 oxymorphone ER 42 urology oncology 42 MEND CABG II 42 Acute Coronary Syndromes ACS 42 Edwards SAPIEN valve 42 Phase III clinical 42 Posidur 42 Phase IIb clinical 42 CURE AF 42 bosutinib 42 recombinant human 42 SPARLON 42 pharmacodynamic PD 42 HERmark assay 42 dermatologic 42 Personalized Oncology 42 Cloretazine R VNP#M 42 nonclinical studies 42 ENDEAVOR IV 42 prospective longitudinal 42 EXPAREL 42 Hepatocellular Carcinoma HCC 42 Val HeFT 41 pharmacokinetic studies 41 AQUAVAN R 41 Puricase PEG uricase 41 postmarket surveillance 41 diagnostic 41 Phase 2b clinical 41 VITAL Trial 41 Phase IIa 41 pharmacodynamic 41 dirucotide 41 ALN HTT 41 Stimuvax R 41 palifosfamide 41 Phase 2b trial 41 maribavir 41 metastatic sarcomas 41 Phase III TRIST 41 QD dosing 41 solid organ transplantation 41 aesthetic dermatological conditions 41 pharmacological therapies 41 Sulonex TM 41 preclinical studies 41 Lauren Silvernail 41 tumor immunology 41 Vasogen Celacade TM 41 transplantation immunology 41 Soliris TM eculizumab 41 TOCOSOL Paclitaxel 41 IIa trial 41 Adlea 41 XL# SAR# 41 prospective multicenter 41 EINSTEIN DVT 41 talactoferrin 41 Renal Cell Carcinoma RCC 41 tecarfarin 41 SYNTAX trial 41 biologics 41 convenient dosing regimen 41 IMS MAT 40 pharmacogenetic tests 40 L. acidophilus 40 Tovaxin ® 40 postmarketing surveillance 40 Bioaccelerate compounds under 40 elacytarabine 40 AA Amyloidosis 40 Sinemet CR 40 OFIRMEV 40 Phase IIb 40 confirmatory clinical 40 pharmacologic 40 Phase III clinical trials 40 HealthCore 40 cardiothoracic surgical 40 Revia 40 relapsed multiple myeloma 40 SUCCEED trial 40 BRIM3 40 abstracts summarizing 40 inhalable 40 clinical pharmacology 40 clazosentan 40 elagolix 40 tacrolimus Prograf 40 www.nextrials.com 40 clinical informatics 39 pivotal Phase III 39 oral ridaforolimus 39 Phase Ia 39 acute ischemic stroke 39 MERLIN TIMI 39 Phase IIb trial 39 OnDose TM 39 EmbraceAC 39 oncology neurology 39 EDEMA3 trial 39 Sunrise Ambulatory Care 39 MAXY alpha 39 pediatric 39 Phase 1b 39 oncology cardiology 39 IIa 39 tolerability profiles 39 Zevalin consolidation 39 rindopepimut 39 ASCEND HF 39 FFR measurements 39 biostatistical 39 interprofessional education 39 CIP ISOTRETINOIN 39 revision hip arthroplasty 38 FFR measurement 38 pharmacokinetic 38 lintuzumab 38 prelicensure 38 TMC# C# 38 hematology microbiology 38 inVentiv Clinical 38 Preclinical 38 Fibrocaps 38 GI endoscopy 38 PEG PAL 38 eRT 38 coronary intervention 38 Tarek Sherif CEO 38 pharmacogenomics 38 ALLEGRO 38 translational research 38 psychometrically sound 38 chlorpheniramine polistirex 38 Meta analyzes 38 pharmacovigilance 38 HGS ETR1 38 stage hypoxia activated 38 Genasense ® 38 Clinical Trial 38 randomized blinded 38 IMPROVE HF 38 guideline concordant 37 LibiGel ® Phase III 37 ophthalmology 37 angiographic outcomes 37 Medidata Rave 37 molecular oncology 37 Gag polymorphisms 37 clinicial 37 data management Clintrial 37 LibiGel Phase III 37 placebo controlled Phase III 37 ENDEAVOR 37 neurology cardiology 37 clinicians 37 phase III ACCLAIM 37 Miescher 37 HORIZONS AMI trial 37 oncologic 37 efficacy 37 ACORN CRO 37 RZN 37 evaluating Nexavar 37 pharmacoeconomics 37 PRIMO CABG 37 oncology virology 36 gynecologic procedures 36 randomized clinical trials 36 peri operative 36 omecamtiv mecarbil 36 viral kinetic 36 immunology 36 AVADO 36 B. Lynne Parshall 36 Phase III VISTA 36 everolimus eluting stents 36 EURIDIS 36 interventional cardiac 36 hematological malignancy 36 clinically